HYBRID EVENT: You can participate in person at Madrid, Spain or Virtually from your home or work.

5th Edition of Cardiology World Conference

September 5-7, 2024 | Madrid, Spain

September 05 -07, 2024 | Madrid, Spain
CWC 2019

Trans-catheter PFO Closure;clinical indications, technique and midterm follow up,Case series

Sahar El Shedoudy, Speaker at Cardiovascular Conference
Tanta university, Egypt
Title : Trans-catheter PFO Closure;clinical indications, technique and midterm follow up,Case series


Implantation of a PFO-occluding device may reduce the risk of recur­rent stroke or transient ischemic attack compared with medical therapy in patients with cryptogenic stroke. However, there is a debate about the indication for closure and the power of secondary prevention by the implanted device. Our aim is to clarify the indications for PFO closure, explaining our protocol to document the degree of the pathogenicity of PFO as a source of right to left shunt, depending of both transoesophageal echocardiographic study and transcranial Doppler. Classification of PFO according to its shape and the implication of the morphology on the chosen device. Demonstrating by multiple movies that PFO could be a simple pathology or a complex one. Explaining the techniques of measurement of the defect and the device implantation during the presentation. Follow up regarding recurrent cerebral events or complication related to the device implantation.


Dr. Sahar El Shedoudy, professor cardiology, instructor of congenital heart disease unit and head of the catheterization laboratory of structural heart disease unit in cardiology department Tanta university. Gaduated as M.B.B.Ch.in 1987 .Master degree of cardiology in 1995, then I joined German Heart center in Munich for 3 years as fellowship in the pediatric cardiology Section, then PHD in cardiology/ interventional pediatric cardiology in 2001.I has published more than 50 research articles in different journals (national and international).